Neumora Therapeutics Inc (NMRA) Stock Price, Quote, News & History

NMRANASDAQ
$1.61
-0.015-0.92%
At close: Jul 21, 5:00 PM EST
$1.65
0.0352.17%
After Hours: 6:52 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-193.40M
Investing Cash Flow (TTM)
124.43M
Financing Cash Flow (TTM)
87.96M
Free Cash Flow (TTM)
-193.40M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
19.00M

Analyst Trends and Forecast

1
Feb
2
Mar
3
Jun
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$208.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.27
Earnings Yield % (TTM)
-81.60%
Earnings Yield % (FWD)
-68.71%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.38

Company Debt

Total Debt
$52.96M
LT Debt
$52.96M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$147.07M
Debt to Equity
0.76
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.62
Close
$1.62
Volume / Avg.
408.15K / 2.22M
Day Range
$1.60 - $1.67
52 Wk Range
0.83 - 3.65
Market Cap
$305.72M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
6.23%
Days to Cover
1.11

About

Sector
Health Care
Industry
Pharmaceuticals
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pip...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Neumora Therapeutics (NMRA) stock?

A

You can purchase shares of Neumora Therapeutics (NASDAQ:NMRA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Neumora Therapeutics (NMRA) competitors?

A

There are no as such competitors for Neumora Therapeutics.

Q

What is the forecast, or price target, for Neumora Therapeutics (NMRA) stock?

A

Neumora Therapeutics has a consensus price target of $5.88.

Q

What is the current price for Neumora Therapeutics (NMRA)?

A

The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $1.65 last updated July 21, 2026 at 6:52 PM EDT.

Q

Does Neumora Therapeutics (NMRA) pay a dividend?

A

There are no upcoming dividends for Neumora Therapeutics.

Q

When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings?

A

Neumora Therapeutics does not have any upcoming earnings scheduled.

Q

Is Neumora Therapeutics (NMRA) going to split?

A

There is no upcoming split for Neumora Therapeutics.

Q

What sector and industry does Neumora Therapeutics (NMRA) operate in?

A

Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.